Literature DB >> 28857345

Basic overview of method validation in the clinical virology laboratory.

Howard Newman1, Jean Maritz2.   

Abstract

Diagnostic virology laboratories are an essential part of the health system and are often relied upon to provide information to clinicians that will inform clinical decision making. It is therefore imperative that diagnostic results produced in the laboratory are reliable. One way of ensuring quality results is by ensuring that all tests are either validated (for tests developed in-house) or verified (for commercial assays that are FDA-approved or CE-labeled). In the diagnostic virology laboratory, these processes can be complex as both qualitative and quantitative measurements for serological and molecular tests are routinely offered. While there are numerous guidelines governing quality assurance in the virology laboratory, all accrediting agencies would insist on tests being validated or verified prior to implementation without providing explicit guidance to the process. As there is no universal guideline on the optimal way to perform validation/verification experiments, this review will provide a basic overview of method validation/verification, specific for clinical virology laboratories, and includes explanation of statistical analysis and acceptance/rejection criteria.
Copyright © 2017 John Wiley & Sons, Ltd.

Keywords:  acceptability criteria; clinical virology laboratory; statistical analysis; validation; verification

Year:  2017        PMID: 28857345     DOI: 10.1002/rmv.1940

Source DB:  PubMed          Journal:  Rev Med Virol        ISSN: 1052-9276            Impact factor:   6.989


  3 in total

1.  Detection and Clinical Implications of Monovalent Rotavirus Vaccine-Derived Virus Strains in Children with Gastroenteritis in Alberta, Canada.

Authors:  Ran Zhuo; Gillian A M Tarr; Jianling Xie; Stephen B Freedman; Daniel C Payne; Bonita E Lee; Charlotte McWilliams; Linda Chui; Samina Ali; Xiaoli Pang
Journal:  J Clin Microbiol       Date:  2021-08-18       Impact factor: 5.948

2.  Quantification of Cardiovascular Disease Biomarkers in Human Platelets by Targeted Mass Spectrometry.

Authors:  Sebastian Malchow; Christina Loosse; Albert Sickmann; Christin Lorenz
Journal:  Proteomes       Date:  2017-11-15

3.  Pooling of sera for human T-cell lymphotropic virus (HTLV) screening in a time of increasing health care expenditure and limited resources.

Authors:  Rafael Xavier da Silva; Karoline Rodrigues Campos; Adele Caterino-de-Araujo
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2020-05-11       Impact factor: 1.846

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.